Accelus

ACCELUS LEADERSHIP

Chris Walsh,
Chief Executive Officer & Co-Founder

Chris Walsh has served as the Chief Executive Officer and Co-Founder of Accelus since April 2016. From 2006 to 2013, Mr. Walsh served as a principal of Integrity Medical Inc., an independent distributor of medical devices. Additionally, Mr. Walsh worked at Stryker Corporation from 1997 to 2004. Mr. Walsh holds a B.A. from the University of Florida.

Kevin McGann,
President

Kevin McGann has served as the President and Chief Commercial Officer of Accelus since July 2021 and previously served as the Chief Commercial Officer of Integrity Implants Inc. from 2019 to 2021 and as the President from 2020 to 2021. Prior to this, Mr. McGann served as the President and Chief Executive Officer of Kallista Partners, LLC from 2017 to 2019. Additionally, Mr. McGann served as the Vice President of Sales of Stryker Corporation from 2015 to 2017. Mr. McGann holds a B.S. in Business Administration from Villanova University.

Wyatt Geist,
Chief Innovation Officer & Co-Founder

Wyatt Geist has served as the Chief Innovation Officer of Accelus since it was established in 2021. Previously, Mr. Geist served as Chief Technology Officer & Co-Founder of Integrity Implants. Mr. Geist started his career as  a chemist before moving into spinal implant distribution and ultimately focusing on product development and company formation. Mr. Geist has over 130 patent applications mostly dealing with medical implants and GPS location technologies.  He has also sold several technologies to large companies including SafeWire to Stryker in 2016. Mr. Geist has served on the boards of SafeWire, Integrity Implants, Accelus, and GeoToll Inc. Mr. Geist holds a B.S. in Microbiology from Auburn University.

Kevin Williamson,
Chief Financial Officer

Kevin Williamson has served as the Chief Financial Officer for Accelus since 2021 and previously served as the Chief Financial Officer of Integrity Implants Inc. from 2020 to 2021 and the Director of Finance of Integrity Implants Inc. from 2019 to 2020. From 2015 to 2019, Mr. Williamson held various roles in the Corporate Finance Department at NuVasive, Inc., a California-based medical devices company, including serving as the Manager of Corporate Finance from 2018 to 2019. Mr. Williamson holds a B.S. in Business Administration, Finance from San Diego State University and an M.B.A. from the University of San Diego – Knauss School of Business.

Brad Clayton,
Chief Technical Officer

Brad Clayton has served as the Chief Technical Officer of Accelus since July 2021. Mr. Clayton has served as the Chief Executive Officer of Practical Navigation, LLC since 2018 and previously served as the Chief Executive Officer of Fusion Robotics LLC from 2019 to 2021. Additionally, Mr. Clayton served as the President of CAMERIC Medical, Inc. from 2017 to 2018 and the Global Director of Robotics for Medtronic Brain and Spine Therapies from 2015 to 2017. Mr. Clayton holds a B.S. in Mechanical Engineering and a B.S. in Chemical Engineering from the University of Nevada, Reno.

Blake Stone, Chief Administrative Officer & General Counsel

Blake Stone has served as the Chief Administrative Officer and General Counsel of Accelus since September 2018. Mr. Stone has also served as the General Counsel of Spinal Elements (formerly Amendia, Inc.), a California-based manufacturer and distributor of spinal implants and related accessories, from 2017 to 2018 and as the Assistant General Counsel of Amendia, Inc. from 2013 to 2017. Mr. Stone holds an A.B. in Government from Harvard University and a J.D. from the University of Georgia School of Law.

Andrew Wolf,
Chief Strategy Officer

Andrew Wolf has served as the Chief Strategy Officer of Accelus since July 2021 and previously served as Integrity Implant’s Chief Operating Officer from June 2018 to July 2021, Executive Vice President of Products from January 2018 to June 2018, and Director of Product Development from January 2017 to January 2018. Prior to joining Integrity Implants, Mr. Wolf served as a Senior Product Manager and Group Manager for NuVasive and as Junior Associate for Falcon Financial Partners. Mr. Wolf holds a B.S. in Finance from San Diego State University.

ACCELUS BOARD OF DIRECTORS

Alex Lukianov

Alex Lukianov has served as the Chairman of the Accelus Board of Directors since 2021. Mr. Lukianov is the Chairman of DuraStat, LLC, a privately held surgical device company, since 2019 and is the founder, Chairman and Chief Executive Officer of Tissue Differentiation Intelligence, LLC, a privately held ultrasound spine company, since 2017. Mr. Lukianov previously served as the Chairman of the Board of Directors of Fusion Robotics, LLC from 2019 to 2021. Additionally, Mr. Lukianov is the founder of NuVasive, Inc. and was the Chief Executive Officer from 1999 and both the Chairman and Chief Executive Officer from 2004 to 2015. Mr. Lukianov was a founder, and served as the Chairman and Chief Executive Officer, of BackCare Group, Inc. from 1996 to 1997. Prior to this, Mr. Lukianov held a variety of senior executive positions, including President of Medtronic Sofamor Danek, Inc. and director of a business unit at Smith+Nephew that brought limb-lengthening technology to the United States from Russia. Mr. Lukianov has served on the boards of directors of Orthofix Medical Inc., Systems Oncology and On Point Technology since 2016. Mr. Lukianov has also served as the Principal of Lukpartners, LLC since 2015. Mr. Lukianov attended Rutgers University and served in the U.S. Navy.

Heather Ace

Heather Ace has served as a director of Accelus since January 2022. Ms. Ace also presently serves as the Chair of Accelus’ Compensation Committee. Additionally, Ms. Ace has served as the Chief Human Resources Officer for Qualcomm since 2020 and served as the Chief Human Resources Officer for Dexcom, Inc. from 2016 to 2020. Ms. Ace also serves on the Executive Committee for Connect, a California-based nonprofit organization, and is a board member of the San Diego Regional Economic Development Corporation, a San Diego-based nonprofit economic development organization. Ms. Ace holds a B.A. in Law & Society from the University of California, Santa Barbara and a J.D. from Santa Clara University School of Law.

Ned Lipes

Ned Lipes has served as a director of Accelus/Integrity Implants since 2016. Mr. Lipes served as the Group President of Stryker Corporation, a Michigan-based medical technologies corporation, from 1988 to 2003. Additionally, Mr. Lipes previously served on the boards of directors of Old Palm Golf Club from 2008 to 2019, the Northern New Jersey Council of the Boy Scouts from 2003 to 2019 and the Leeds Foundation from 2014 to 2020. Mr. Lipes has served as the President of One Singer Island Condo Association since 2007. Mr. Lipes holds a B.A. in Administration Science from Colby College and an M.B.A. from Harvard Business School.

Joseph Swedish

Joseph R. Swedish has served as a director of Accelus since 2022. Mr. Swedish is a Co-Founder and Partner at Concord Health Partners and a member of Concord’s Investment Committee. He also serves as senior advisor to Anthem, Inc., a leading health benefits provider, where he previously served as executive Chairman from late 2017 to his retirement in May 2018. Before that, Mr. Swedish was Chief Executive Officer of Anthem from 2013 until late 2017 and Chairman of the company’s board from 2015 until 2018. Prior to joining Anthem, he was the division president of Hospital Corporation of America from 1993 to 1998, President and Chief Executive Officer of Centura Health from 1999 to 2004 and then served as President and Chief Executive Officer of Trinity Health from 2004 to 2013. Mr. Swedish serves on the board of directors for IBM Corporation, CDW, Mesoblast Limited (chairman), and Centrexion Therapeutics. He is a member and the former chairman of Duke University’s Fuqua School of Business Board of Visitors. Previously, Mr. Swedish served as board chairman of America’s Health Insurance Plans (AHIP), and chairman of the board, Catholic Health Association. He has also held board and advisory positions with American Hospital Association, Coventry Health Care, Inc., RehabCare Group, Inc., BankFIRST, Cross Country, Inc., National Quality Forum, American Hospital Association’s Institute for Diversity in Healthcare Management, and Loyola University Chicago. Mr. Swedish holds a bachelor’s degree from the University of North Carolina at Charlotte and an M.S. from Duke University.

Chris Walsh Accelus CEO

Chris Walsh

Chris Walsh has served as the Chief Executive Officer and Co-Founder, and as a director, of Accelus since April 2016. From 2006 to 2013, Mr. Walsh served as a principal of Integrity Medical Inc., an independent distributor of medical devices. Additionally, Mr. Walsh worked at Stryker Corporation from 1997 to 2004. Mr. Walsh holds a B.A. from the University of Florida.

Nathan Ward

Nathan Ward has served as a director of Accelus/Integrity Implants since 2016. Mr. Ward is a Managing Partner and Co-Founder of Palm Beach Capital, where his primary responsibilities include sourcing, structuring, and negotiating investment transactions. Post-acquisition, he works with portfolio companies on various operational and financial matters including add-on acquisitions, financings, expansion and growth initiatives, risk management, and strategic direction. Nate is a member of PBCP’s Investment Committee and has served on the Board of Directors of more than fifteen former and current Palm Beach Capital portfolio companies. He has led investments for the firm in a variety of industries including healthcare, business process outsourcers, aerospace, consumer products, logistics, and business-to-business services. Nate enjoys investing in and building businesses with his management teams. Prior to founding Palm Beach Capital, Nate started his career as a corporate lender at Bank of America in Virginia and then as VP of Mergers and Acquisitions at Workflow Management in Florida. Nate holds an undergraduate Finance degree from James Madison University and a M.B.A. from the University of Richmond.

Steven Whitlock

Steven Whitlock has served as a director of Accelus since January 2022. Mr. Whitlock has over 30 years of experience in the orthopedic industry, and has served as the Managing Director of Spindletop Capital Management LLC since 2011 and as an officer of Spindletop Health Acquisition Corp., a newly formed SPAC, since 2021. Mr. Whitlock co-founded LDR Spine USA in 2004, where he served as the President and Chief Executive Officer from 2004 to 2006 and as the Vice President of Clinical Study Relations until 2008. Additionally, Mr. Whitlock served on the board of directors of LDR Spine USA from 2004 to 2010. Mr. Whitlock also co-founded Path4 Ventures in 2004 and served as an Operating Venture Partner with PTV Sciences from 2008 to 2011. During his time with Path4 Ventures, Mr. Whitlock co-founded Spinal Restoration Inc. in 2004 and served on the board of directors from 2004 to 2014. Mr. Whitlock also held board observer rights with Ortho Kinematics Inc. from 2009 to 2018. Mr. Whitlock began his career with Centerpulse Orthopedics (formerly Intermedics and Sulzer Orthopedics) in 1990 where he held various executive management roles in Global Research and Development, New Business Development, and Global Products in the areas of total joints, sports medicine, trauma, and orthobiologics. Mr. Whitlock has also served as the Owner and President of Straightway Ventures LLC since 2009, where he has held various roles as a Management Consultant for Molecular Matrix Inc. from 2018 to 2019, Bioventus LLC from 2019 to 2020, Integrity Implants Inc. from 2020 to 2021 and TruCell LLC from 2021 to present. Mr. Whitlock holds a B.S. in Mechanical Engineering from Texas A&M University and an M.B.A. from Embry–Riddle Aeronautical University.

Lisa P. Young

Lisa P. Young has served as a director of Accelus since January 2022. Ms. Young also presently serves as the Chair of Accelus’ Audit and Finance Committee. Ms. Young worked at Ernst & Young (EY) for 36 years where she served in a number of leadership roles, most recently serving as a Senior Global Client Service Partner until her retirement in 2021. Ms. Young serves as the Vice President of the Board of Trustees for the Columbus Museum of Art, as the Treasurer of the Board of Trustees for the Columbus School for Girls and a member of the Texas Tech University Rawls College of Business Advisory Council. Previously, Ms. Young served on the Accounting Advisory Board for Fisher College of Business at The Ohio State University and on EY’s Americas Advisory Council. Ms. Young holds a B.B.A. in Finance & Accounting from Texas Tech University and is a certified public accountant.